Literature DB >> 29657364

Sleep onset insomnia, daytime sleepiness and sleep duration in relationship to Toxoplasma gondii IgG seropositivity and serointensity.

Zaki Ahmad1, Yara W Moustafa2, John W Stiller3, Mary A Pavlovich4, Uttam K Raheja5, Claudia Gragnoli6, Soren Snitker7, Sarra Nazem8, Aline Dagdag1, Beverly Fang1, Dietmar Fuchs9, Christopher A Lowry10, Teodor T Postolache11.   

Abstract

Toxoplasma gondii (T. gondii) infects central nervous tissue and is kept in relative dormancy by a healthy immune system. Sleep disturbances have been found to precipitate mental illness, suicidal behavior and car accidents, which have been previously linked to T. gondii as well. We speculated that if sleep disruption, particularly insomnia, would mediate, at least partly, the link between T. gondii infection and related behavioral dysregulation, then we would be able to identify significant associations between sleep disruption and T. gondii. The mechanisms for such an association may involve dopamine (DA) production by T. gondii, or collateral effects of immune activation necessary to keep T. gondii in check. Sleep questionnaires from 2031 Old Order Amish were analyzed in relationship to T. gondii-IgG antibodies measured by enzyme-linked immunosorbent assay (ELISA). Toxoplasma gondii seropositivity and serointensity were not associated with any of the sleep latency variables or Epworth Sleepiness Scale (ESS). A secondary analysis identified, after adjustment for age group, a statistical trend toward shorter sleep duration in seropositive men (p = 0.07). In conclusion, it is unlikely that sleep disruption mediates links between T. gondii and mental illness or behavioral dysregulation. Trending gender differences in associations between T. gondii and shorter sleep need further investigation.

Entities:  

Keywords:  Epworth Sleepiness Scale; Old Order Amish; Toxoplasma gondii; excessive daytime sleepiness; insomnia; sleep duration

Year:  2017        PMID: 29657364      PMCID: PMC5894504          DOI: 10.1515/pterid-2017-0010

Source DB:  PubMed          Journal:  Pteridines        ISSN: 0933-4807            Impact factor:   0.581


  78 in total

1.  Milk intolerance in children with persistent sleeplessness: a prospective double-blind crossover evaluation.

Authors:  A Kahn; M J Mozin; E Rebuffat; M Sottiaux; M F Muller
Journal:  Pediatrics       Date:  1989-10       Impact factor: 7.124

Review 2.  Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation.

Authors:  Michael R Irwin; Richard Olmstead; Judith E Carroll
Journal:  Biol Psychiatry       Date:  2015-06-01       Impact factor: 13.382

3.  Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample.

Authors:  Nora Hamdani; Claire Daban-Huard; Mohamed Lajnef; Jean-Romain Richard; Marine Delavest; Ophélia Godin; Emmanuel Le Guen; François-Eric Vederine; Jean-Pierre Lépine; Stéphane Jamain; Josselin Houenou; Philippe Le Corvoisier; Masayuki Aoki; Helene Moins-Teisserenc; Dominique Charron; Rajagopal Krishnamoorthy; Robert Yolken; Faith Dickerson; Ryad Tamouza; Marion Leboyer
Journal:  J Affect Disord       Date:  2012-12-27       Impact factor: 4.839

4.  Dopaminergic role in stimulant-induced wakefulness.

Authors:  J P Wisor; S Nishino; I Sora; G H Uhl; E Mignot; D M Edgar
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

5.  Insomnia is frequent in schizophrenia and associated with night eating and obesity.

Authors:  Laura B Palmese; Pamela C DeGeorge; Joseph C Ratliff; Vinod H Srihari; Bruce E Wexler; Andrew D Krystal; Cenk Tek
Journal:  Schizophr Res       Date:  2011-12       Impact factor: 4.939

6.  Chronic insomnia and activity of the stress system: a preliminary study.

Authors:  A N Vgontzas; C Tsigos; E O Bixler; C A Stratakis; K Zachman; A Kales; A Vela-Bueno; G P Chrousos
Journal:  J Psychosom Res       Date:  1998-07       Impact factor: 3.006

7.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

Review 8.  Treating the health, quality of life, and functional impairments in insomnia.

Authors:  Andrew D Krystal
Journal:  J Clin Sleep Med       Date:  2007-02-15       Impact factor: 4.062

Review 9.  A cognitive model of insomnia.

Authors:  A G Harvey
Journal:  Behav Res Ther       Date:  2002-08

10.  Dopamine acts through Cryptochrome to promote acute arousal in Drosophila.

Authors:  Shailesh Kumar; Dechun Chen; Amita Sehgal
Journal:  Genes Dev       Date:  2012-05-11       Impact factor: 11.361

View more
  4 in total

1.  Toxoplasma gondii infection and insomnia: A case control seroprevalence study.

Authors:  Cosme Alvarado-Esquivel; Sergio Estrada-Martínez; Alma Rosa Pérez-Álamos; Agar Ramos-Nevárez; Karina Botello-Calderón; Ángel Osvaldo Alvarado-Félix; Raquel Vaquera-Enríquez; Gustavo Alexis Alvarado-Félix; Antonio Sifuentes-Álvarez; Carlos Alberto Guido-Arreola; Elizabeth Rábago-Sánchez; Leandro Saenz-Soto
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

2.  Toxoplasma gondii IgG associations with sleep-wake problems, sleep duration and timing.

Authors:  Celine C Corona; Man Zhang; Abhishek Wadhawan; Melanie L Daue; Maureen W Groer; Aline Dagdag; Christopher A Lowry; Andrew J Hoisington; Kathleen A Ryan; John W Stiller; Dietmar Fuchs; Braxton D Mitchell; Teodor T Postolache
Journal:  Pteridines       Date:  2019-02-19       Impact factor: 0.581

3.  No evidence for airborne transmission of Toxoplasma gondii in a very high prevalence area in Lancaster County.

Authors:  Abhishek Wadhawan; Dolores E Hill; Aline Dagdag; Hira Mohyuddin; Patrick Donnelly; Jeffrey L Jones; Teodor T Postolache
Journal:  Pteridines       Date:  2018-12-31       Impact factor: 0.581

Review 4.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.